Shockwave Medical to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Shockwave Medical (NASDAQ: SWAV) announced participation in two upcoming virtual investor conferences to showcase its innovative Intravascular Lithotripsy (IVL) technology for treating calcified cardiovascular disease. The conferences are:

• Wells Fargo Healthcare Conference on September 8, 2022, at 9:45 a.m. ET.
• Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 2:05 p.m. ET.

Live and archived webcasts will be available on the company's website, potentially attracting investor interest in their pioneering treatment methods.

SANTA CLARA, Calif., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences:

• The 2022 Wells Fargo Healthcare Conference
  Fireside Chat on Thursday, September 8, 2022, at 9:45 a.m. Eastern Time.

• The Morgan Stanley 20th Annual Global Healthcare Conference
  Fireside Chat on Tuesday, September 13, 2022, at 2:05 p.m. Eastern Time.

Interested parties may access live and archived webcasts of the events on the “Investors” section of the company’s website at: https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.

Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

 

FAQ

What dates will Shockwave Medical participate in investor conferences?

Shockwave Medical will participate in the Wells Fargo Healthcare Conference on September 8, 2022, and the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022.

What time is the Wells Fargo Healthcare Conference for Shockwave Medical?

The Wells Fargo Healthcare Conference participant chat is scheduled for September 8, 2022, at 9:45 a.m. Eastern Time.

Where can I watch Shockwave Medical's investor conference webcasts?

You can access live and archived webcasts of Shockwave Medical's investor conferences on the 'Investors' section of their official website.

What technology does Shockwave Medical develop?

Shockwave Medical develops Intravascular Lithotripsy (IVL) technology designed to treat severely calcified cardiovascular disease.

What is the purpose of Intravascular Lithotripsy (IVL)?

Intravascular Lithotripsy (IVL) aims to establish a new standard of care by using sonic pressure waves to treat calcified plaque in cardiovascular disease.